Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 12/5/23 → 12/5/24 |
Funding
- Boehringer Ingelheim Pharmaceuticals, Inc. (Prot #1368-0104)
Prot #1368-0104: A Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Spesolimab in the Treatment of Patients with Netherton Syndrome
- Paller, Amy (PD/PI)
Project: Research project